Blake DeWayne Babcock, M.D.

//Blake DeWayne Babcock, M.D.
Blake DeWayne Babcock, M.D.2021-12-04T20:56:04+00:00

Blake DeWayne Babcock, M.D.

Education

Louisiana State University Health Sciences Center–Shreveport – M.D. (2010)

Louisiana State University, B.S. Major: Chemistry, Major: Biology, Minor: Latin (2004)

Work Experience

Physician/Surgeon – Palm Beach General Surgery, LLC dba Miami Dade Surgical Group (2019 – Present)

Fellow – Complex General Surgical Oncology, Loma Linda University Medical Center, Department of Surgery (2017-2019)

Resident – General Surgery, Drexel University College of Medicine, Hahnemann University Hospital (2011-2017)

Post-Doctoral Research Fellow – Department of Surgery, Drexel University College of Medicine PI: Wilbur B. Bowne, MD (2012-2014)

Intern – General Surgery, Drexel University College of Medicine, Hahnemann University Hospital (2010-2011)

Research Assistant – Department of Psychiatry, LSUHSC – Shreveport, PI: Donard S. Dwyer, PhD (2005-2006)

Chemistry Teacher – Jesuit High School – New Orleans (2005)

General Surgery – American Board of Surgery

Florida Medical License: ME141501

Society of Surgical Oncology (2017-Present)

American College of Surgeons – Resident and Associate Society (2012-2017)

Association for Academic Surgery (2012-2014)

Chief Administrative Research Fellow, Department of Surgery, Drexel University College of Medicine (2013-2014)

Secretary ACS-RAS Communications Committee (2012-2013)

Commission on Cancer Award for Best Manuscript (2019)
Southern California Chapter of the American College of Surgeons Annual Meeting

Commission on Cancer Award for Best Manuscript (2018)
Southern California Chapter of the American College of Surgeons Annual Meeting

Dmitry Nikitin Award for Resident of the Year (2016-2017)
Department of Surgery, Drexel University College of Medicine

Golden Scalpel Award for Excellence in Teaching (2016-2017)
Drexel University College of Medicine

Joel C. Roselyn Resident Researcher of the Year Award (2013-2014)
Department of Surgery, Drexel University College of Medicine

Pseudomyxoma Peritonei Foundation Research Travel Grant (2013)

Babcock BD, Shaikh MF, Poor AE, Bowne WB. (2015). Abdominal Pain and
Abdominal Mass. In William G. Cance, MD, FACS,Herbert Chen, MD, FACS,
Gregory J. Jurkovich, MD, FACS, John H. Pemberton, MD, FACS, Taylor S.
Riall, MD, PhD, FACS,David A. Spain, MD, FACS, Scott J. Swanson, MD,
FACS, R. James Valentine, MD, FACS (Ed.), Scientific American Surgery (pp.
Chapter 5.1). Hamilton: Decker Intellectual Properties Inc.

Thadi A, Morano WF, Khalili M, Babcock BD, Shaikh MF, Foster DS, Piazza Y,
Gleeson EM, Goldstein E, Steele L, Campbell PM, Lin BO, Pincus MR, Bowne
WB. Molecular Targeting of H/MDM-2 Oncoprotein in Human Colon Cancer
Cells and Stem-like Colonic Epithelial-derived Progenitor Cells. Anticancer Res.
2021 Jan;41(1):27-42
PMID: 33419797

Ji L, Selleck MJ, Morgan JW, Xu J, Babcock BD, Shavlik D, Wall NR, Langridge
WH, Lum SS, Garberoglio CA, Reeves ME, Solomon N, Namm JP, Senthil M.
Gastric Cancer Peritoneal Carcinomatosis Risk Score. Ann Surg Oncol. 2020
Jan; 27(1):240-247.
PMID: 31346896

Babcock BD, Jabo B, Selleck MJ, Aljehani MA, Morgan JW, Namm JP,
Kazanjian K, Senthil M. Factors predictive of outcomes after cytoreductive
surgery and heated intraperitoneal chemotherapy for colon and appendiceal
carcinomatosis – single institution experience. Am Surgeon. Volume: 84 issue:
10, page(s): 1575-1579. 2018 Oct 1
https://doi.org/10.1177/000313481808401007

Luca F, Craigg DK, Senthil M, Selleck MJ, Babcock BD, Reeves ME,
Garberoglio CA. Sexual and urinary outcomes in robotic rectal surgery: review
of the literature and technical considerations. Updates Surg. 2018 Aug 17.
PMID: 30120743

Babcock BD, Aljehani MA, Jabo B, Choi AH, Morgan JW, Selleck MJ, Luca F,
Raskin E, Reeves ME, Garberoglio CA, Lum SS, Senthil M. High-Risk Stage II
Colon Cancer: Not All Risks Are Created Equal. Ann Surg Oncol. 2018
Jul;25(7):1980-1985.
PMID: 29675762

Shaikh MF, Morano WF, Lee J, Gleeson E, Babcock BD, Michl J, Sarafraz-
Yazdi E, Pincus MR, Bowne WB. Emerging Role of MDM2 as Target for Anti-
Cancer Therapy: A Review. Ann Clin Lab Sci. 2016 Dec; 46(6):627-634.
PMID: 27993876

Foster D, Shaikh MF, Gleeson E, Babcock BD, Ringold D, Bowne WB.
Palliative Surgery for Advanced Cancer: Identifying Evidence-Based Criteria forPatient Selection: Case Report and Review of Literature. J Palliat Med. 2016
Jan; 19(1):22-9
PMID: 26565437

Foster D, Shaikh MF, Gleeson E, Babcock BD, Lin J, Ownbey RT, Hysell ME,
Ringold D, Bowne WB. Pancreatic mucinous cystic neoplasm in a transgender
patient. World J Surg Oncol. 2015 Jun 24; 13:205.
PMID: 26104783

Davitt K, Babcock BD, Fenelus M, Poon CK, Sarkar A, Trivigno V, Zolkind PA,
Matthew SM, Grin’kina N, Orynbayeva Z, Shaikh MF, Adler V, Michl J, Sarafraz-
Yazdi E, Pincus MR, Bowne WB. The anti-cancer peptide, PNC-27, induces
tumor cell necrosis of a poorly differentiated nonsolid tissue human leukemia cell
line that depends on expression of HDM-2 in the plasma membrane of these
cells. Ann Clin Lab Sci. 2014 Summer; 44(3):241-8.
PMID: 25117093

Williams AD, Sanchez A, Hou JS, Rubin RR, Hysell ME, Babcock BD, Shaikh
MF, Weingarten MS, Bowne WB. Retroperitoneal Castleman’s disease:
advocating a multidisciplinary approach for a rare clinical entity. World J Surg
Oncol. 2014 Feb 4; 12:30.
PMID: 24495409

Babcock JM, Babcock BD, Schwartz MZ. Maintaining a Sufficient and Quality
Physician Workforce: The Role of For-profit Medical Schools. Health Serv
Insights. 2013 Sep 23; 6:87-98.
PMID: 25114564

8/17 – present “Exosomal analysis of a murine model of colorectal peritoneal
carcinomatosis” Principal Investigator- Maheswari Senthil, M.D.,
LLUMC – Loma Linda, CA
Co-investigator

9/12 – 7/14 “Novel p53 derived peptides to treat murine model of peritoneal
carcinomatosis”; Principal Investigator- Wilbur Bowne, M.D.,
DUCOM/Hahnemann University Hospital – Philadelphia, PA
Co-investigator

6/12 – 7/14 “The Cure Project” – Use of novel peptides to treat kRas-p21
supercomplex in pancreatic adenocarcinoma
Principal Investigator- Wilbur Bowne, M.D., DUCOM/Hahnemann
University Hospital – Philadelphia, PA
Co-investigator

5/07 – 3/09 “Peripheral Perfusion Quantified Using Thermal Modulation and
Whole Body Relativized IR Images”; Principal Investigator- Cuthbert
O. Simpkins, M.D.; Chief of Trauma Surgery and Critical Care,
LSUHSC—Shreveport
Co-investigator

11/05 – 6/06 “Anti-psychotic induced lipid accumulation in C. elegans”; Principal
Investigator-
Donard S. Dwyer, PhD; Professor of Psychiatry, LSUHSC—
Shreveport
Co-investigator

1/25/19
Southern California Chapter of the American College of
Surgeons – Annual Meeting
Santa Barbara, California Improved Survival with Immunotherapy but Lack of Synergistic
Effect with Radiation for Stage IV Melanoma of the Head and
Neck. Blake Babcock MD, Medora Rodrigues MD MPH, Donovan
Kearns, Naveenraj Solomon MD, Mark E. Reeves MD PhD, Maheswari
Senthil MD, Carlos A. Garberoglio MD, Jukes P. Namm MD
Loma Linda University Cancer Center, Loma Linda, CA

5/12/18
Southern California Chapter of the American College of
Surgeons – Annual Meeting
Indian Wells, California
Disparities in Access to Immunotherapy and Outcomes in
Metastatic
Cutaneous Melanoma. Blake Babcock, MD, Donovan Kearns, Joanne
Lee, Medora Rodrigues, MPH, Naveen Solomon, MD, Mark E. Reeves,
MD, PhD, Carlos A. Garberoglio, MD, Sharon Lum, MD Maheswari
Senthil, MD, Jukes P. Namm, MD
Loma Linda University Cancer Center, Loma Linda, CA

5/11/18
Southern California Chapter of the American College of
Surgeons – Annual Meeting
Indian Wells, California
Factors Predictive of Outcomes after Cytoreductive Surgery
and Heated Intraperitoneal Chemotherapy for Colon and
Appendiceal Carcinomatosis – Single Institution Experience.
Blake Babcock, MD, Brice Jabo, MD, Matthew Selleck, DO, Mayada A.
Aljehani, DrPH, Mark Reeves, MD, PhD, Carlos
Garberoglio, MD, Jukes Namm, MD, Kevork Kazanjian MD, Maheswari
Senthil, MD
Loma Linda University Cancer Center, Loma Linda, CA

3/23/18
Society of Surgical Oncology – Annual Cancer Symposium
Chicago, IL
High-risk Stage II Colon Cancer: Not All Risks Are Created
Equal. Blake
Babcock, MD, Mayada A. Aljehani, DrPH, Brice Jabo, MD, MPH,
Audrey Choi, MD, John W. Morgan, DrPH, MPH, Matthew Selleck, DO,
Fabrizio Luca, MD, Elizabeth Raskin, MD, Mark Reeves, MD, Carlos
Garberoglio, MD, Sharon Lum, MD, Maheswari Senthil, MD
Loma Linda University Cancer Center, Loma Linda, CA
2/5/15
Association for Academic Surgery – Academic Surgical
Congress
Las Vegas, NV
Anti-Cancer Activity of a p53-Derived Peptide in a
Colon Cancer Peritoneal Carcinomatosis Model. B.
D. Babcock, M. F. Shaikh, K. Davitt, Y. Piazza, T.
Meckmongkol, V. Purohit, R. Patel, M. Estioko, E. Gleeson,
M. R. Pincus, W. B. Bowne, MD. Drexel University
College of Medicine Departments of Surgery and
Pathology, New York Harbor View VA Medical Center,
Brooklyn, NY

2/10/14
Philadelphia Academy of Surgery – Resident Research
Competition
Philadelphia, PA
Establishing Anti-Cancer Mechanism and Activity of A
Novel p53-Derived Peptide In A Colon Cancer
Peritoneal Carcinomatosis Model. Blake D. Babcock, MD,
Katlin Davitt, Mohammad F. Shaikh, MD, Yelena Piazza, MD,
Javier Rojas, MD, Vaishali Purohit, Raj Patel, Marc Estioko,
John Lee, Teerin Meckmongkol, MD, PhD, Victor Adler MD,
PhD, D. Scott Lind, MD, Matthew R. Pincus, MD., PhD, Wilbur
B. Bowne, MD. Drexel University College of Medicine
Departments of Surgery and Pathology, New York Harbor View
VA Medical Center, Brooklyn, NY